History of the Prothrombin Time and Development of the INR Leon Poller European Concerted Action on Anticoagulation.

Slides:

Advertisements

Similar presentations

INR Purpose Monitor the coagulation of blood for those on anti-coagulation therapy Monitor for therapeutic levels of medication Monitor for.

Advertisements

Basic coagulation techniques and Quality control issues

QUALITY CONTROL IN HEMATOLOGY

General Approach of Haemostasis

Quality Control in the Coagulation Laboratory Brisbane Australia Robyn Coleman.

Good laboratory practices with waived test systems

POC INR Testing Rural and Remote Session 2015 CADTH SYMPOSIUM Janice Mann MD Knowledge Mobilization, CADTH.

General Approach of Haemostasis Prothrombin Time (Continue) Lecture 5:

Intermediate methods in observational epidemiology 2008 Quality Assurance and Quality Control.

Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.

Quality Assurance.

One Stage Factor V Assay

Quality Assurance in the clinical laboratory

Module 5 Postanalytical Phase of Laboratory Testing.

Quality Assurance.

WARFARIN AN OVERVIEW.

©2007 Wortham Laboratories, Inc.

ABC of Quality Control A problem based approach RT ERASMUS NHLS / FACULTY OF HEALTH SCIENCES, UNIVERSITY OF STELLENBOSCH 20th July, 2007, Bela Bela.

Neurology APTT, PTT, PT, INR. Neurology APTT, PTT, PT, INR.

Biostatistics: Measures of Central Tendency and Variance in Medical Laboratory Settings Module 5 1.

MLAB 1227-Coagulation Keri Brophy-Martinez Preanalytical Issues in Coagulation Testing.

  The prothrombin time is therefore the time required for the plasma to clot after an excess of thromboplastin and an optimal concentration of calcium.

Quality Control Lecture 5

In this exercise, two tests will be performed to screen for defective clotting factors. The formation of thrombin in the plasma samples will be inhibited.

Dr. S. Parthasarathy MD DA DNB PhD (physio) Mahatma Gandhi medical college and research institute, puducherry – India Prothrombin time.

APTT. Causes of prolonged aPTTs: 1.Spurious (common to many Coag tests): – dilution (saline, Tx), underfilled specimen, clotted, prolonged tourniquet.

Anticoagulants Reducing the risk Amanda Powell & Sue Wooller May 2014.

Investigation of Haemostasis MS. c. program Lab-9.

Activated Partial Thromboplastin Time (aPTT)

VERIFICATION OF BLOOD COLLECTION SYSTEM GIAN LUCA SALVAGNO, MD, PhD University of Verona, Italy.

Laboratory Medicine: Basic QC Concepts M. Desmond Burke, MD.

Quality Control Internal QC External QC. -Monitors a test's method precision and analytical bias. -Preparation of quality control samples and their interpretation.

CLINICAL LABORATORIES THE ROLE: A science that uses sophisticated instruments and techniques with the application of theoretical knowledge to perform complex.

Forecast 2 Linear trend Forecast error Seasonal demand.

Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.

Local Enhanced Service Care bundles Dr Andy Kilpatrick, Clinical Lead.

Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Transition of Patients From Blinded Study Drug to.

Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Influenza Vaccination and Vitamin K Antagonist Treatment:

QC - THE OUT-OF-CONTROL PROBLEM 謝昆穎 Assistant Product Manager, CDG BIO-RAD Laboratories, Taiwan Branch.

Date of download: 7/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Choice of Antithrombotic Therapy for Stroke Prevention.

Date of download: 7/11/2016 From: The International Normalized Ratio (INR) for Monitoring Warfarin Therapy: Reliability and Relation to Other Monitoring.

Date of download: 9/18/2016 From: Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants Ann Intern Med. 1997;127(3): doi: /

Lesson 1-9 Quality Assessment.

General Approach in Investigation of Hemostasis

General Approach of Haemostasis

One Stage Factor V Assay

General Approach of Haemostasis

Volume 14, Issue 10, Pages (September 2013)

Basic Estimation Techniques

Warfarin Toxicity Treatment & Management

Evaluation of APTT clot waveform analysis by IL ACL TOP® in patients with Haemophilia and comparison to clot waveform analysis with MDA® 180 P-TH-568 Aghighi.

Hematology 425 Quality Assurance

RE-CIRCUIT Trial design: Patients with atrial fibrillation undergoing catheter ablation were randomized to uninterrupted dabigatran 150 mg twice daily.

Basic Estimation Techniques

Activated Partial Thromboplastin Time (aPTT)

How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults Arif H. Kamal, MD, Ayalew.

Regression Computer Print Out

Which NVAF patients are candidates for NOACs?

General Approach in Investigation of Hemostasis

Anticoagulation early after mechanical valve replacement: Improved management with patient self-testing Jess L. Thompson, MD, Harold M. Burkhart, MD,

Introduction To Medical Technology

▪Internal quality control:

Volume 14, Issue 10, Pages (September 2013)

Point-of-Care vs Laboratory INR Testing to Optimize Anticoagulation Management.

Quality Assessment The goal of laboratory analysis is to provide the accurate, reliable and timeliness result Quality assurance The overall program that.

General Approach in Investigation of Hemostasis

Arman Qamar et al. JACC 2018;71:

Self-managed anticoagulation: results from a two-year prospective randomized trial with heart valve patients Pushpinder Sidhu, Hugh O O’Kane The Annals.

Variable CD7 Expression on T Cells in the Leukemic Phase of Cutaneous T Cell Lymphoma (Sézary Syndrome) Eric C. Vonderheid, Amy Kotecha, Christine M.

Presentation transcript:

History of the Prothrombin Time and Development of the INR Leon Poller European Concerted Action on Anticoagulation

Mean results with different thromboplastins in 30 patients Poller L. Acta Haemat. 32: (1964)

Mean doses of warfarin from different geographical locations. Striped boxes indicate rabbit reagent.

Bleeding events with Simplastin (ISI 2.5) and Manchester Reagent (ISI 1.0) control. Hull et al (1982). Prothrombin Ratio 2.0 Simplastin = 4.7 INR.

Figure 1 Figure 2

ACCP Consensus Meeting

An example of the orthogonal regression line

Calibration lines from the seventeen participant centres

The hierarchical structure of thromboplastin calibration

IRP = International Reference Preparation. *Now discontinued. IRR = International Reference Reagent. IS = International Standard. International reference preparations for thromboplastins 2003

INR = Prothrombin Ratio (PR) ISI

Causes of Erroneous INRs (1) Pretest variables Erroneous prothrombin ratio determination Variations in manual technique Coagulometer effects Incorrect normal value due to: Failure to use MNPT Error in MNPT due to: (a) unrepresentative selection; (b) technical faults; (c) non-use of geometric mean.

Causes of Erroneous INRs (2) Incorrect ISI calibration Drift of ISI Poor distribution of coumarin test samples, inadequate numbers of test samples Incorrect choice of IRP Incorrect transformation of PR to INR ‘Rogue’ plasmas (outliers)

Errors in PT Determination Pretest variables blood collection citrate container storage time temperature evacuated and non-evaculated tubes variations in manual technique coagulometers The overall trend of coagulometers is to accelerate the normal PT with the PR distorted. System-related ISI of limited value.

Coagulometer Effects of ACL and MLA

The ISI of thromboplastins and effect of ISI on the width of therapeutic range in prothrombin ratios.

Percentage deviation of mean INR from the IRP value with various thromboplastin reagents during the induction phase Reagent C Reagent B Reagent A Reagent D

Reliability of monitor INR on CoaguChek Mini and TAS PT-NC at 10 centres No. of samples Displayed INR “true” INR % difference Mean displayed INR difference TAS PT-NC CoaguChek Mini Br Med J 2003;327:30-34

DAILY TELEGRAPH 23 SEPTEMBER 2003

Proportion of time in INR ranges *INR results for all weeks, including first 3 weeks Lancet 1998;352:1505-9